Day By Day - Mediclinic International Plc (MDC) Short term view - MEDICLINIC INTERNATIONAL PLC : The resistance has been passed.

Report

Day By Day

Louis-Clément AZAIS d'UHART

EUR 108.58 For Business Accounts Only

Short term view - MEDICLINIC INTERNATIONAL PLC : The resistance has been passed.

The resistance has been passed, the trend becomes positive as we now have a succession of ascending peaks and troughs.The next target is at 868.00 p. The invalidation level is below 760.00 p.

Arguments :
- The resistance has been passed.
- Prices are breaking above the moving...

27/01/2017 1 EN

Underlying

Mediclinic International Plc

See profile

GB00B8HX8Z88 London Stock Exchange United Kingdom

Provider

Day By Day

DayByDay is an independent research company providing global macro and single stock analysis, recommendation and allocation based purely on behavioural finance methods. Those include long term cycle analysis, sentiment analysis, and technical trigger. DayByDay serves all clients in need of practical and precise publications to make effective market decisions, on any time horizon, from a few hours to a few years.

See profile

Analysts

Louis-Clément AZAIS d'UHART

Other Reports on these Companies

EQS Group AG

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc 24-May-2023 / 12:10 GMT/BST FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the...

May 24, 2023 May 24, 2023 1 EN

EQS Group AG

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc 22-May-2023 / 12:51 GMT/BST FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the...

May 22, 2023 May 22, 2023 1 EN

EQS Group AG

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc 19-May-2023 / 13:16 GMT/BST FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the...

May 19, 2023 May 19, 2023 1 EN

Short term view - GBP-CHF : The major resistance is close.

The trend remains neutral. Prices will have to break above the peak at CHF 1.3104 for the trend to be positive again with an invalidation level below CHF 1.2740.Arguments :- The major resistance is close.- The moving average is capping prices.

EUR 102.54

November 2, 2018 November 2, 2018 1 EN

Valérie GASTALDY

Valérie GASTALDY

La tendance est toujours neutre. Il faut franchir le sommet Ã 1,3104 CHF pour que la tendance devienne positive avec une invalidation sous 1,2740 CHF.Arguments :- La rÃ©sistance majeure est proche.- La moyenne mobile sert de rÃ©sistance.

EUR 102.54

November 2, 2018 November 2, 2018 1 FR

Valérie GASTALDY

Valérie GASTALDY

Short term view - GBP-USD : Pull-back

The trend is momentarily interrupted by a consolidation on a shorter time horizon but prices remain below the invalidation level at $1.3210. It can resume at anytime towards the target at $1.2600.Arguments :- Prices are pulling back to the major resistance level (previously a support). The fall will resume afterwards.- The falling moving average confirms our opinion.

EUR 102.54

November 2, 2018 November 2, 2018 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Short term view - MEDICLINIC INTERNATIONAL PLC : The resistance has been passed.

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Short term view - GBP-CHF : The major resistance is close.

Analyse court terme - GBP-CHF : La rÃ©sistance majeure est proche.

Short term view - GBP-USD : Pull-back

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe